Literature DB >> 19210651

Pulmonary alveolar proteinosis in a patient with Behcet's disease.

Michihiro Uchiyama1, Tsuyoshi Nagao, Aritoshi Hattori, Tatsuya Fujii, Toshio Ichiwata, Koh Nakata, Kenzaburo Tani, Takuya Hayashi.   

Abstract

Secondary pulmonary alveolar proteinosis (PAP) has been described in several clinical settings that can be grouped into three main categories: infections of the lung; haematological malignancies and other conditions that alter the patient's immune status; and exposure to inhaled chemicals and minerals. Recent studies reported that anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody was present in the serum of patients with idiopathic PAP but not in patients with secondary PAP or in normal subjects. The present report describes the interesting case of a patient with Behcet's disease and PAP. The absence of anti-GM-CSF antibodies in this patient suggested a diagnosis of secondary PAP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19210651     DOI: 10.1111/j.1440-1843.2008.01450.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  4 in total

1.  Pulmonary alveolar proteinosis as an unusual pattern of lung involvement in Sjögren syndrome.

Authors:  Eugene Park; Hae-Rim Kim; Hee Joung Kim; Sang-Heon Lee
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

2.  Release of B cell-activating factor of the TNF family in bronchoalveolar lavage from Behçet's disease with pulmonary involvement.

Authors:  Agnès Hamzaoui; Hanene Chelbi; Fayçal Hai Sassi; Kamel Hamzaoui
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

3.  Alveolar proteinosis in Behçet's disease.

Authors:  Cuneyt Tetikkurt; Seza Tetikkurt; Imran Ozdemir; Cigdem Zuhur; Nihal Bayar
Journal:  Multidiscip Respir Med       Date:  2010-08-31

Review 4.  Beyond "Big Eaters": The Versatile Role of Alveolar Macrophages in Health and Disease.

Authors:  Miriam Hetzel; Mania Ackermann; Nico Lachmann
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.